4//SEC Filing
Bhatt Nailesh 4
Accession 0001193125-25-317206
CIK 0002078856other
Filed
Dec 11, 7:00 PM ET
Accepted
Dec 12, 11:55 AM ET
Size
5.1 KB
Accession
0001193125-25-317206
Insider Transaction Report
Form 4
Bhatt Nailesh
Director
Transactions
- Other
Common Stock
2025-12-02+2,082→ 2,082 total
Footnotes (1)
- [F1]On December 2, 2025, Hyperliquid Strategies Inc (the "Company") completed its previously announced business combination (the "Closing"), pursuant to the Business Combination Agreement, dated as of July 11, 2025 (as amended on September 22, 2025, the "BCA"), by and among the Company, Sonnet BioTherapeutics Holdings, Inc. ("Sonnet"), Rorschach I LLC, TBS Merger Sub Inc. and Rorschach Merger Sub, LLC . In connection with the Closing, Ms. Nailesh Bhatt received 2,082 shares of common stock, par value $0.01 per share, of the Company, in exchange of certain securities of Sonnet Ms. Bhatt held prior to the Closing.
Documents
Issuer
Hyperliquid Strategies Inc
CIK 0002078856
Entity typeother
Related Parties
1- filerCIK 0001806525
Filing Metadata
- Form type
- 4
- Filed
- Dec 11, 7:00 PM ET
- Accepted
- Dec 12, 11:55 AM ET
- Size
- 5.1 KB